Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational study.

Marukutira T, Gunaratnam P, Douglass C, Jamil MS, McGregor S, Guy R, Gray RT, Spelman T, Horyniak D, Higgins N, Giele C, Crowe SM, Stoove M, Hellard M.

Medicine (Baltimore). 2020 Feb;99(8):e19289. doi: 10.1097/MD.0000000000019289.

2.

The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.

Jo O, Schlicht S, Slavin J, Di Bella C, Pang G, Powell G, Spelman T, Choong PF.

Eur J Radiol. 2020 Jan 23;125:108846. doi: 10.1016/j.ejrad.2020.108846. [Epub ahead of print]

PMID:
32062570
3.

Accuracy of non-contrast quiescent-interval single-shot and quiescent-interval single-shot arterial spin-labelled magnetic resonance angiography in assessment of peripheral arterial disease in a diabetic population.

Lam A, Perchyonok Y, Ranatunga D, Lukies MW, Richmond D, Hornsey EK, McColl B, Heidrich J, Ko PH, Spelman T, Chuen J, Edelman RR, Lim RP.

J Med Imaging Radiat Oncol. 2020 Feb;64(1):35-43. doi: 10.1111/1754-9485.12987.

PMID:
32043319
4.

Multi-directional bubble generated streaming flows.

Spelman TA, Stephan O, Marmottant P.

Ultrasonics. 2019 Dec 2:106054. doi: 10.1016/j.ultras.2019.106054. [Epub ahead of print]

PMID:
31948810
5.

The effects of sublingual nitroglycerin administration in coronary computed tomography angiography.

Kutaiba N, Lukies M, Galea M, Begbie M, Smith G, Kearney L, Spelman T, Lim RP.

Clin Imaging. 2019 Dec 24;60(2):194-199. doi: 10.1016/j.clinimag.2019.11.019. [Epub ahead of print]

PMID:
31927493
6.

Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.

Einsiedel L, Pham H, Au V, Hatami S, Wilson K, Spelman T, Jersmann H.

ERJ Open Res. 2019 Dec 2;5(4). pii: 00001-2019. doi: 10.1183/23120541.00001-2019. eCollection 2019 Oct.

7.

Patients with High-Disease-Activity Relapsing-Remitting Multiple Sclerosis in Real-World Clinical Practice: A Population-Based Study in Sweden.

Spelman T, Freilich J, Anell B, Wong SL, Hillert J.

Clin Ther. 2019 Dec 31. pii: S0149-2918(19)30587-9. doi: 10.1016/j.clinthera.2019.11.018. [Epub ahead of print]

PMID:
31899001
8.

Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial.

Peel T, Astbury S, Cheng AC, Paterson D, Buising K, Spelman T, Tran-Duy A, de Steiger RS; ASAP Trial Group.

BMJ Open. 2019 Nov 3;9(11):e033718. doi: 10.1136/bmjopen-2019-033718.

9.

The prognostic significance of attenuated psychotic symptoms in help-seeking youth.

Hazan H, Spelman T, Amminger GP, Hickie I, McGorry PD, Phillips LJ, Purcell R, Wood SJ, Yung AR, Nelson B.

Schizophr Res. 2020 Jan;215:277-283. doi: 10.1016/j.schres.2019.10.016. Epub 2019 Oct 12.

PMID:
31615738
10.

The effect of mindfulness training prior to total joint arthroplasty on post-operative pain and physical function: A randomised controlled trial.

Dowsey M, Castle D, Knowles S, Monshat K, Salzberg M, Nelson E, Dunin A, Dunin J, Spelman T, Choong P.

Complement Ther Med. 2019 Oct;46:195-201. doi: 10.1016/j.ctim.2019.08.010. Epub 2019 Aug 12.

PMID:
31519279
11.

Patient-related risk factors for unplanned 30-day readmission following total knee arthroplasty: a protocol for a systematic review and meta-analysis.

Gould D, Dowsey M, Spelman T, Jo I, Kabir W, Trieu J, Choong P.

Syst Rev. 2019 Aug 22;8(1):215. doi: 10.1186/s13643-019-1140-3.

12.

Risk of secondary progressive multiple sclerosis: A longitudinal study.

Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, Terzi M, Hupperts R, Boz C, Lechner-Scott J, Pucci E, Bergamaschi R, Van Pesch V, Ozakbas S, Granella F, Turkoglu R, Iuliano G, Spitaleri D, McCombe P, Solaro C, Slee M, Ampapa R, Soysal A, Petersen T, Sanchez-Menoyo JL, Verheul F, Prevost J, Sidhom Y, Van Wijmeersch B, Vucic S, Cristiano E, Saladino ML, Deri N, Barnett M, Olascoaga J, Moore F, Skibina O, Gray O, Fragoso Y, Yamout B, Shaw C, Singhal B, Shuey N, Hodgkinson S, Altintas A, Al-Harbi T, Csepany T, Taylor B, Hughes J, Jun JK, van der Walt A, Spelman T, Butzkueven H, Kalincik T.

Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9.

PMID:
31397221
13.

Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.

Vodanovich DA, Spelman T, May D, Slavin J, Choong PFM.

ANZ J Surg. 2019 Sep;89(9):1045-1050. doi: 10.1111/ans.15348. Epub 2019 Jul 30.

PMID:
31364245
14.

Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.

Marukutira T, Yin D, Cressman L, Kariuki R, Malone B, Spelman T, Mawandia S, Ledikwe JH, Semo BW, Crowe S, Stoove M, Hellard M, Dickinson D.

Medicine (Baltimore). 2019 Jun;98(23):e15994. doi: 10.1097/MD.0000000000015994.

15.

Injection drug network characteristics as a predictor of injection behaviour.

Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M.

Epidemiol Infect. 2019 Jan;147:e173. doi: 10.1017/S095026881900061X.

16.

Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.

Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ; PrEPX Study Team.

JAMA. 2019 Apr 9;321(14):1380-1390. doi: 10.1001/jama.2019.2947.

17.

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis.

Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):458-468. doi: 10.1136/jnnp-2018-319831. Epub 2019 Jan 13.

PMID:
30636699
18.

Statistical Process Control Charts for Monitoring Staphylococcus aureus Bloodstream Infections in Australian Health Care Facilities.

Imam N, Spelman T, Johnson SA, Worth LJ.

Qual Manag Health Care. 2019 Jan/Mar;28(1):39-44. doi: 10.1097/QMH.0000000000000201.

PMID:
30586121
19.

Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study.

Andersen JB, Moberg JY, Spelman T, Magyari M.

Front Immunol. 2018 Nov 23;9:2706. doi: 10.3389/fimmu.2018.02706. eCollection 2018.

20.

The impact of older age on patient outcomes following primary total knee arthroplasty.

Murphy BPD, Dowsey MM, Spelman T, Choong PFM.

Bone Joint J. 2018 Nov;100-B(11):1463-1470. doi: 10.1302/0301-620X.100B11.BJJ-2017-0753.R6.

PMID:
30418062
21.

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators.

ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.

22.

Description of social contacts among student cases of pandemic influenza during the containment phase, Melbourne, Australia, 2009.

van Gemert C, McBryde ES, Bergeri I, Sacks-Davis R, Vally H, Spelman T, Sutton B, Hellard M.

Western Pac Surveill Response J. 2018 Oct 1;9(5 Suppl 1):27-34. doi: 10.5365/wpsar.2018.9.5.003. eCollection 2018 Winter.

23.

Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model.

Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U.

PLoS One. 2018 Sep 27;13(9):e0204643. doi: 10.1371/journal.pone.0204643. eCollection 2018.

24.

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D, Pucci E, Grand'Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo JL, Barnett M, Girard M, Trojano M, Grammond P, Duquette P, Sola P, Alroughani R, Hupperts R, Vucic S, Kalincik T, Van Pesch V, Lechner-Scott J.

Mult Scler. 2018 Oct;24(12):1569-1577. doi: 10.1177/1352458518798147. Epub 2018 Sep 20.

PMID:
30234431
25.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

Kister I, Spelman T, Patti F, Duquette P, Trojano M, Izquierdo G, Lugaresi A, Grammond P, Sola P, Ferraro D, Grand'Maison F, Alroughani R, Terzi M, Boz C, Hupperts R, Lechner-Scott J, Kappos L, Pucci E, Hodgkinson S, Solaro C, Butzkueven H.

J Neurol Sci. 2018 Aug 15;391:72-76. doi: 10.1016/j.jns.2018.06.001. Epub 2018 Jun 2.

PMID:
30103975
26.

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

Trojano M, Butzkueven H, Kappos L, Wiendl H, Spelman T, Pellegrini F, Chen Y, Dong Q, Koendgen H, Belachew S; Tysabri® Observational Program (TOP) Investigators.

Mult Scler Relat Disord. 2018 Aug;24:11-19. doi: 10.1016/j.msard.2018.04.020. Epub 2018 May 2.

27.

Treatment of scabies using a tea tree oil-based gel formulation in Australian Aboriginal children: protocol for a randomised controlled trial.

Thomas J, Davey R, Peterson GM, Carson C, Walton SF, Spelman T, Calma T, Dettwiller P, Tobin J, McMillan F, Collis P, Naunton M, Kosari S, Christenson JK, Bartholomaeus A, McEwen J, Fitzpatrick P, Baby KE.

BMJ Open. 2018 May 31;8(5):e018507. doi: 10.1136/bmjopen-2017-018507.

28.

Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)].

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Menoyo JLS, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 May;22:166. doi: 10.1016/j.msard.2018.02.025. Epub 2018 Feb 24. No abstract available.

PMID:
29807821
29.

Body Mass Index Is Associated With All-cause Mortality After THA and TKA.

Dowsey MM, Choong PFM, Paxton EW, Spelman T, Namba RS, Inacio MCS.

Clin Orthop Relat Res. 2018 Jun;476(6):1139-1148. doi: 10.1007/s11999.0000000000000108.

30.

The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial.

Rasmussen TA, McMahon JH, Chang JJ, Audsley J, Rhodes A, Tennakoon S, Dantanarayana A, Spelman T, Schmidt T, Kent SJ, Morcilla V, Palmer S, Elliott JH, Lewin SR.

Lancet HIV. 2018 May;5(5):e221-e230. doi: 10.1016/S2352-3018(18)30040-7. Epub 2018 Apr 8.

PMID:
29643011
31.

Central and peripheral line-associated bloodstream infections in Australian neonatal and paediatric intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2016.

Worth LJ, Daley AJ, Spelman T, Bull AL, Brett JA, Richards MJ.

J Hosp Infect. 2018 May;99(1):55-61. doi: 10.1016/j.jhin.2017.11.021. Epub 2017 Dec 6.

PMID:
29222036
32.

What Is the Impact of Advancing Age on the Outcomes of Total Hip Arthroplasty?

Murphy BPD, Dowsey MM, Spelman T, Choong PFM.

J Arthroplasty. 2018 Apr;33(4):1101-1107.e1. doi: 10.1016/j.arth.2017.11.010. Epub 2017 Nov 13.

PMID:
29208330
33.

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod.

Fragoso YD, Spelman T, Boz C, Alroughani R, Lugaresi A, Vucic S, Butzkueven H, Terzi M, Havrdova E, Horakova D, Granella F, Olascoaga J, Sánchez-Menoyo JL, Pucci E, Barnett M, Brooks JBB, Haartsen J; Lymphopenia and Efficacy of Fingolimod MSBase sub-study Investigators.

Mult Scler Relat Disord. 2018 Jan;19:105-108. doi: 10.1016/j.msard.2017.11.018. Epub 2017 Nov 22.

PMID:
29182993
34.

Impaired placental autophagy in placental malaria.

Dimasuay KG, Gong L, Rosario F, McBryde E, Spelman T, Glazier J, Rogerson SJ, Beeson JG, Jansson T, Devenish RJ, Boeuf P.

PLoS One. 2017 Nov 10;12(11):e0187291. doi: 10.1371/journal.pone.0187291. eCollection 2017.

35.

Patient Characteristics, Procedural and Safety Outcomes of Bariatric Surgery in England: a Retrospective Cohort Study-2006-2012.

Sun S, Borisenko O, Spelman T, Ahmed AR.

Obes Surg. 2018 Apr;28(4):1098-1108. doi: 10.1007/s11695-017-2978-x.

36.

Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Teh BW, Harrison SJ, Allison CC, Slavin MA, Spelman T, Worth LJ, Thursky KA, Ritchie D, Pellegrini M.

Front Immunol. 2017 Oct 5;8:1247. doi: 10.3389/fimmu.2017.01247. eCollection 2017.

37.

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

Kalincik T, Manouchehrinia A, Sobisek L, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Girard M, Prat A, Duquette P, Grammond P, Sola P, Hupperts R, Grand'Maison F, Pucci E, Boz C, Alroughani R, Van Pesch V, Lechner-Scott J, Terzi M, Bergamaschi R, Iuliano G, Granella F, Spitaleri D, Shaygannejad V, Oreja-Guevara C, Slee M, Ampapa R, Verheul F, McCombe P, Olascoaga J, Amato MP, Vucic S, Hodgkinson S, Ramo-Tello C, Flechter S, Cristiano E, Rozsa C, Moore F, Luis Sanchez-Menoyo J, Laura Saladino M, Barnett M, Hillert J, Butzkueven H; MSBase Study Group.

Brain. 2017 Sep 1;140(9):2426-2443. doi: 10.1093/brain/awx185.

PMID:
29050389
38.

Are People Who Inject Drugs Frequent Users of Emergency Department Services? A Cohort Study (2008-2013).

Nambiar D, Spelman T, Stoové M, Dietze P.

Subst Use Misuse. 2018 Feb 23;53(3):457-465. doi: 10.1080/10826084.2017.1341921. Epub 2017 Oct 16.

PMID:
29035611
39.

Antibiotic Prescribing Practices for Prevention of Surgical Site Infections in Australia: Increased Uptake of National Guidelines after Surveillance and Reporting and Impact on Infection Rates.

Bull AL, Worth LJ, Spelman T, Richards MJ.

Surg Infect (Larchmt). 2017 Oct;18(7):834-840. doi: 10.1089/sur.2017.119. Epub 2017 Sep 8.

PMID:
28885898
40.

Central line-associated bloodstream infections in Australian ICUs: evaluating modifiable and non-modifiable risks in Victorian healthcare facilities.

Spelman T, Pilcher DV, Cheng AC, Bull AL, Richards MJ, Worth LJ.

Epidemiol Infect. 2017 Oct;145(14):3047-3055. doi: 10.1017/S095026881700187X. Epub 2017 Sep 4.

PMID:
28868995
41.

Influence of changing endotracheal tube cuff management on antibiotic use for ventilator-associated pneumonia in a tertiary intensive care unit.

Darvall JN, Thevarajan I, Iles S, Rechnitzer T, Spelman T, Harley N.

Crit Care Resusc. 2017 Sep;19(3):247-253.

PMID:
28866975
42.

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

Kalincik T, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Lechner-Scott J, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Solaro C, Grand'Maison F, Hupperts R, Prevost J, Sola P, Ferraro D, Terzi M, Butler E, Slee M, Kermode A, Fabis-Pedrini M, McCombe P, Barnett M, Shaw C, Hodgkinson S, Butzkueven H; MSBase Study Group.

Mult Scler. 2018 Oct;24(12):1617-1626. doi: 10.1177/1352458517728812. Epub 2017 Aug 31. Erratum in: Mult Scler. 2017 Dec;23(14):NP1.

PMID:
28857680
43.

Three-dimensional knee kinematic analysis during treadmill gait: Slow imposed speed versus normal self-selected speed.

Mannering N, Young T, Spelman T, Choong PF.

Bone Joint Res. 2017 Aug;6(8):514-521. doi: 10.1302/2046-3758.68.BJR-2016-0296.R1.

44.

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

Lorscheider J, Jokubaitis VG, Spelman T, Izquierdo G, Lugaresi A, Havrdova E, Horakova D, Trojano M, Duquette P, Girard M, Prat A, Grand'Maison F, Grammond P, Pucci E, Boz C, Sola P, Ferraro D, Spitaleri D, Lechner-Scott J, Terzi M, Van Pesch V, Iuliano G, Bergamaschi R, Ramo-Tello C, Granella F, Oreja-Guevara C, Butzkueven H, Kalincik T; MSBase Study Group.

Neurology. 2017 Sep 5;89(10):1050-1059. doi: 10.1212/WNL.0000000000004330. Epub 2017 Aug 9.

45.

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.

Dendle C, Gilbertson M, Spelman T, Stuart RL, Korman TM, Thursky K, Opat S, McQuilten Z.

Sci Rep. 2017 Jun 30;7(1):4395. doi: 10.1038/s41598-017-04495-x.

46.

Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registry.

Spelman T, Frisell T, Piehl F, Hillert J.

Mult Scler. 2018 Jul;24(8):1087-1095. doi: 10.1177/1352458517713668. Epub 2017 Jun 26.

PMID:
28649912
47.

Upper extremity non-contrast magnetic resonance venography (MRV) compared to contrast enhanced MRV and ultrasound.

Lim RP, Hornsey E, Ranatunga D, Hao H, Smith J, Spelman T, Chuen J, Goodwin M.

Clin Imaging. 2017 Sep - Oct;45:51-57. doi: 10.1016/j.clinimag.2017.05.020. Epub 2017 Jun 6.

PMID:
28601736
48.

Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network, 2008-2015.

Worth LJ, Spelman T, Holt SG, Brett JA, Bull AL, Richards MJ.

J Hosp Infect. 2017 Sep;97(1):93-98. doi: 10.1016/j.jhin.2017.05.018. Epub 2017 May 30.

PMID:
28576453
49.

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study.

Kappos L, Butzkueven H, Wiendl H, Spelman T, Pellegrini F, Chen Y, Dong Q, Koendgen H, Belachew S, Trojano M; Tysabri® Observational Program (TOP) Investigators.

Mult Scler. 2018 Jun;24(7):963-973. doi: 10.1177/1352458517709619. Epub 2017 May 30.

50.

Prognostic indicators in pediatric clinically isolated syndrome.

Iaffaldano P, Simone M, Lucisano G, Ghezzi A, Coniglio G, Brescia Morra V, Salemi G, Patti F, Lugaresi A, Izquierdo G, Bergamaschi R, Cabrera-Gomez JA, Pozzilli C, Millefiorini E, Alroughani R, Boz C, Pucci E, Zimatore GB, Sola P, Lus G, Maimone D, Avolio C, Cocco E, Sajedi SA, Costantino G, Duquette P, Shaygannejad V, Petersen T, Fernández Bolaños R, Paolicelli D, Tortorella C, Spelman T, Margari L, Amato MP, Comi G, Butzkueven H, Trojano M; Italian iMedWeb Registry and the MSBase Registry.

Ann Neurol. 2017 May;81(5):729-739. doi: 10.1002/ana.24938.

PMID:
28439957

Supplemental Content

Loading ...
Support Center